Accelerate Clinical Trial Enrollment and Ensure
Health Equity

Diversify Your Clinical Trials and Stay FDA Compliant with REDPlanUP
REDPlanUP is a unique state-of-the-art solution that provides insights into the race and ethnicity diversity of patients treated by investigators. It helps pharmaceutical companies identify investigators treating diverse patient populations as directed by FDA for clinical trials.

Our product ensures quicker enrollment of patients in clinical trials for pharma and life sciences organizations through appropriate representation of all races and ethnicities in the trials.

Schedule a Demo

Our Value Proposition

Inclusion of Un- and Under-Represented Participants:
REDPlanUP ensures that clinical trials represent the full diversity of the US population, allowing for safer and more effective medications for everyone.
Savings for Pharma
Sponsors:
By partnering with investigators best suited for their specific trials, REDPlanUP helps pharmaceutical sponsors optimize costs and resources.
Faster Medications to
Market:
REDPlanUP fast tracks drug development and market launch with quicker enrollment of patients with diverse racial backgrounds.
Targeting Investigators with Underrepresented Patients:
REDPlanUP identifies investigators with experience in treating patients from various underrepresented races and ethnicities, thus facilitating better patient recruitment.
Schedule a Demo

How It Works

FDA new regulations require patient recruitment in clinical trials to reflect the diversity of the affected population in the US.
REDPlanUP meets this criteria by offering a robust race diversity index and comprehensive demographic and investigator information on previous and ongoing trials. Our product utilizes patient-level medical and pharmacy claims data along with open-source data assets to glean insights into the diversity mix of patients treated by specific physicians.

All data is handled in a HIPAA-compliant manner.

Robust Race
Diversity Index
.
REDPlanUP provides a comprehensive race diversity index which helps in understanding the diversity mix of the patient population being treated by a specific physician.
Demographic
and Investigator
Information
Our solution includes demographic and investigator information on previous and current trials. It equips Pharmaceutical Clinical Operations teams and/or Contract Research Organizations (CROs) to target investigators for clinical trials.
Historical and
Current Trial
Involvement
REDPlanUp provides insights into previous and current trials conducted by each investigator, aiding in better decision-making for new trials.
Schedule a Demo

We Have More To Offer

Other products that
drive business impact

View All
DataAMPlify
Leverage deeper analytics for all your business needs through our robust data analytics platform
Create a repository of ready-to-use patient data to solve complex business challenges
Accelerate clinical trial enrolment by partnering with key investigators who have an equitable patient mix
Drive business impact by identifying and connecting with the right group of KOLs at the right time
Contact Us
At Chryselys, we are committed to partnering with you on this essential health equity initiative. To learn more about REDPlanUP and the new FDA regulations, write to us at
info@chryselys.com
Follow Us
Products

RED Plan Up
PIT
KIT
Data Amplify
NBA
DataFusionIQ
Commercial Insights Platform
Payer Intelligence
Patient Analytics

Solutions
Analytics
Sales
Market Access
Research & Development
Data
US Office
530 Lytton Avenue, 2nd Floor, Palo Alto, CA 94301

Corporate Commons, 6200
Stoneridge Mall Road,
3rd Floor, Pleasanton,
CA 94588

India Office
Prestige Cosmopolitan, 1st floor,
Door 36, Sardar Patel road,
Guindy, Chennai
Copyright © 2023 Chryselys All rights reserved.